Berkshire Hathaway, the company of veteran investor Warren Buffett, has reduced its stake in famous pharma companies like Abbvie Inc., Bristol-Myers Squibb Co in the second quarter of the current financial year. The company has ended its entire stake in another pharma company Biogen Inc.. In return, the company has increased its stake in Berkshire Hathaway supermarket chain kroger Co, Rh Com, Marsh rival Aon Plc Shs CI A.
Berkshire Hathaway also reduced stake in General Motors
Berkshire Hathaway has achieved 10.44 per cent growth in General Motors. General Motors has sold 6 crore shares of the company. At the end of June, it has a stake of $ 3.5 billion in this company. The company has also reduced stake in Liberty Global Plc. and Axalta Coating Systems. However, the company has not reduced its stake in Apple, Bank of America. Berkshire Hathaway has invested $462 million in Organon & Co Common stock. However, it has reduced its stake of $ 411 million in Axlta Coating systems Ltd. Berkshire Holding has a stake in this company since 2015. Berkshire Hathaway holds $121 billion in Apple, while Bank of America holds $42 billion. There has been no decline in investment in this quarter. In the second quarter, Berkshire Hathaway sold $1.1 billion worth of shares compared to what it had invested.
ICRA estimates 20 percent growth rate in the first quarter, but will remain neutral due to the huge decline of last year
Nifty Pharma index declined
Meanwhile, the company bought its own shares worth $1.43 billion between January and July. Its shares touched a new high on May 7, but in comparison, it has now registered a fall of two percent. Meanwhile, in India, the Nifty’s pharma index has lost two per cent to four per cent.